info@biomedres.us   +1 (720) 414-3554
  One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA

Biomedical Journal of Scientific & Technical Research

April, 2019, Volume 16, 5, pp 1-4

Case Report

Case Report

Bilateral Geographic Atrophy of the Retina in Acquired Immune Deficiency Syndrome Associated with Cryptococcal Meningitis

Evangelia Chalkiadaki1, Michail Tzortzakakis2, Chrysoula Florou3 and Emmanouil Alexakis4*

Author Affiliations

1251 General Air-Force Hospital, Athens, Greece

2Tzaneio Prefecture General Hospital of Piraeus, Piraeus, Greece

3Glyfada’s Regional Health Unit, Social Insurance Institute, Athens, Greece.

3National Technical University of Athens, School of Chemical Engineering, Athens, Greece

Received: March 28, 2019 | Published: April 04, 2019

Corresponding author: National Technical University of Athens, School of Chemical Engineering, Athens, Greece

DOI: 10.26717/BJSTR.2019.16.002906

Abstract

Cryptococcal infections may occur in 5-10% of patients with AIDS and are associated with both direct and indirect ocular complications. It may result in meningitis and secondary ocular involvement such as chorioretinitis and endophthalmitis. We describe a rare case of extensive geographic atrophy of the retina in an HIV-patient presenting 10 years after hospitalization for cryptococcal meningitis.

Keywords: Cryptococcal Meningitis; Geographic atrophy

Abbreviations: CMV: Cytomegalovirus; CF: Counting Fingers; OCT: Optical Coherence Tomography; RPE: Retinal Pigment Epithelium

Introduction

Ocular manifestations are found in the majority of patients with AIDS. The most common ocular finding is a noninfectious occlusive microangiopathy known as HIV retinopathy. Nevertheless, visually more significant and devastating are opportunistic ocular infections such as cytomegalovirus (CMV) retinitis (the most common), progressive retinal necrosis, acute retinal necrosis, bacterial, fungal and protozoal retinochoroiditis [1]. Fungal ocular infections include Pneumocystis choroiditis, Histoplasma chorioretinitis, Cryptococcal choroiditis and Candidiasis. There seems to be a distinction between those diseases that have the potential to affect both eyes of HIVpatients, such as CMV retinitis, acute retinal necrosis, progressive outer retinal necrosis, HIV-related ischaemic microvasculopathy, ocular syphilis, ocular tuberculosis, cryptococcal meningitis, ocular toxic or allergic drug reactions and disorders which tend to occur unilaterally. Ocular toxoplasmosis, Kaposi’s sarcoma of the ocular adnexae and conjunctival neoplasias tend to affect one eye only [2]. Cryptococcus is the most common life-threatening fungal pathogen that affects patients with HIV infection [2]. It is an encapsulated, basidiomycetic yeast, commonly found in pigeon excreta and rotten wood. The yeast causes Cryptococcosis, an infectious disease with worldwide distribution and wide array of clinical presentations. Approximately 95% of Cryptococcal infections are caused by Cryptococcus neoformans [3]. It is a well-known infection in immunocompromised individuals but can occasionally occur in immunocompetent individuals as well. It enters the body through inhalation and can spread to the eye in the bloodstream or from the CNS via the optic nerve. It has a propensity to seed the central nervous system during hematogenous dissemination and can result in a severe, chronic form of meningitis. Occasionally, the resulting meningitis is further complicated by visual loss.

In undeveloped areas, loss of visual acuity is a relatively common occurrence and is seen in up to 10% of patients with AIDS and Cryptococcus infection. The etiology of visual complications associated with cryptococcal meningitis remains unclear. Possible explanations for visual loss include direct infiltration of the optic nerve or optic tracts by the fungus, inflammatory compression of the optic nerve, adhesive arachnoiditis, amphotericin B toxicity used as a therapeutic regimen, cerebral vasculitis, intracranial hypertension and very rarely cryptococcal choroiditis [4]. We present a case of an HIV-positive patient with bilateral, permanent visual loss complicating cryptococcal meningitis.

Case Report

A 51-year-old Caucasian HIV-positive woman presented to our clinic complaining of decreased vision in both eyes for the last 10 years. She was diagnosed with HIV infection 20 years ago and was hospitalized for cryptococcal meningitis 10 years ago. She mentioned that, at that time, her CD4+ count was 40 cells/μL. Upon examination, visual acuity was counting fingers (CF) 2 ft in both eyes and intraocular pressure was 14 mm Hg bilaterally by noncontact tonometry. The anterior segment examination in both eyes was unremarkable, but fundoscopy revealed geographic atrophy and pigment deposition in the macula and the mid- periphery of the fundus of both eyes (Figure 1). We performed an optical coherence tomography (OCT) which showed atrophy of the retinal layers in the macula (Figure 2). We also performed fundus autofluorescence which showed retinal pigment epithelium (RPE) atrophy (Figure 3) and fluorescein angiography which revealed multiple window defects in the macula and the mid-periphery of the fundus of both eyes corresponding to the retinochoroidal atrophy, with no sign of active disease (Figure 4). We established the diagnosis of geographic atrophy of the retina due to a past retinitis. The differential diagnosis of retinitis included VZV retinitis, HSV retinitis, CMV retinitis, Cryptococcal retinitis, ocular syphilis and Tb retinochoroiditis. We asked for a blood examination and a serology test for HSV-1 and HSV-2 (IgG, IgM), VZV (IgG, IgM), CMV (IgG, IgM), VDRL, FTA-ABS, RPR and Quantiferon-TB Gold test. We also performed a Mantoux tuberculin test and a Chest X-ray. All our results were negative for a past herpetic, cytomegalovirus, syphilitic or tuberculosis infection. At the time of our examination, her CD4+ count was 430 cells/μL, she was in a pretty good general health and was under HAART. Due to the medical history of cryptococcal meningitis and the fact that the patient mentioned that she was first experiencing an alteration in visual acuity two months after her hospitalization 10 years ago, we assumed that Cryptococcus was the cause for the geographic atrophy of the retina.

Figure 1: Colour fundus photography of the Right (a) and the Left (b) eye, showing geographic atrophy and pigment deposition in the macula and mid-periphery of the patient.

Figure 2: Optical Coherence Tomography (OCT) of the left eye showing retinal atrophy in the macula.

Figure 3: Fundus autofluorescence (FAF) of the Right (a) and the Left (b) eye showing atrophy of the retinal pigment epithelium (RPE) in the macula and the mid-periphery.

Figure 4: Fluorescein angiography (FA) of the Right (a) and the Left (b) eye showing multiple window defects corresponding to the patches of chorioretinal atrophy.

We established the diagnosis of geographic atrophy of the retina due to a past retinitis. The differential diagnosis of retinitis included VZV retinitis, HSV retinitis, CMV retinitis, Cryptococcal retinitis, ocular syphilis and Tb retinochoroiditis. We asked for a blood exam and a serology test for HSV-1 and HSV-2 (IgG, IgM), VZV (IgG, IgM), CMV (IgG, IgM), VDRL, FTA-ABS, RPR and QuantiferonTB Gold test. We also performed Mantoux test and a Chest X-ray. All our results were negative for a past herpetic, cytomegalovirus, syphilitic or tuberculosis infection. At the time of our examination, her CD4+ count was 430 cells/μL, she was in a pretty good general health and was under HAART. Due to the medical history of cryptococcal meningitis and the fact that the patient mentioned that she was first experiencing an alteration in visual acuity two months after her hospitalization 10 years ago, we assumed that Cryptococcus was the cause for the geographic atrophy of the retina.

Discussion

Cryptococcus neoformans is a fungal pathogen that causes almost half a million deaths each year. Cryptococcal meningitis preferentially occurs in people with impaired cell-mediated immunity and is a major HIV-related opportunistic infection occurring when the CD4+ cell count falls below 100 cells/μL. With widespread implementation of successful antiretroviral therapy (HAART), the incidence of HIV-associated cryptococcosis has decreased significantly in most developed countries, although the incidence in other at-risk populations has not changed [3]. There have been found multiple yeast virulence factors of Cryptococcus neoformans. The 3 classical and most prominent factors include capsule formation, melanin pigment production, and thermotolerance [5].

Ocular signs and symptoms such as ocular palsies and papilloedema have been noted in a substantial proportion of cases of cryptococcal meningitis, even before the AIDS epidemic [6]. Several other ocular manifestations of cryptococcosis have been identified since then. Ocular involvement may occur directly with vasculitis and retinal exudate, such as in multifocal choroiditis, or more commonly indirectly with papilloedema and ocular motility dysfunction. Visual loss can also be the result of endophthalmitis due to extensive retinal disease with or without vitritis [7]. In some cases, visual loss may be owing to optic nerve infiltration by yeasts and cryptococcomas in the visual pathway, including the optic nerve, chiasm and tract. Irreversible blindness may be also due to vascular compromise of the optic nerve from intracranial hypertension [3]. There seem to be two patterns of visual loss in immunodeficient patients, one with the rapid onset of visual loss with limited effective treatment options, and the other with gradual visual deterioration. This difference probably relies on the different etiologic mechanisms. The rapid onset of vision loss (3 days) is thought to result from direct infiltration of the optic nerve or adhesive or inflammatory arachnoiditis [8,9], while visual loss over a period of more than four weeks has been attributed more commonly to long term intracranial hypertension [9].

Our patient presented 10 years after her visual acuity started to decline, limiting our capability for a certain diagnosis. She suffered permanent, bilateral visual loss due to bilateral geographic atrophy. There were found extensive, multiple foci of retinal atrophy both in the macula and the periphery of the fundus of both eyes indicating a past retinal infection. There was no sign of reactivation of the disease. Serological tests were negative for many possible causative factors such as herpetic infection. Taking into consideration her past medical history, we regarded this to be a case of past cryptococcal chorioretinitis. Unfortunately, there was no therapeutic regimen to be done by the time of presentation to our clinic.

References

Case Report

Bilateral Geographic Atrophy of the Retina in Acquired Immune Deficiency Syndrome Associated with Cryptococcal Meningitis

Evangelia Chalkiadaki1, Michail Tzortzakakis2, Chrysoula Florou3 and Emmanouil Alexakis4*

Author Affiliations

1251 General Air-Force Hospital, Athens, Greece

2Tzaneio Prefecture General Hospital of Piraeus, Piraeus, Greece

3Glyfada’s Regional Health Unit, Social Insurance Institute, Athens, Greece.

4National Technical University of Athens, School of Chemical Engineering, Athens, Greece

Received: March 28, 2019 | Published: April 04, 2019

Corresponding author: Emmanouil Alexakis, School of Chemical Engineering, Greece

DOI: 10.26717/BJSTR.2019.16.002906

Abstract

Cryptococcal infections may occur in 5-10% of patients with AIDS and are associated with both direct and indirect ocular complications. It may result in meningitis and secondary ocular involvement such as chorioretinitis and endophthalmitis. We describe a rare case of extensive geographic atrophy of the retina in an HIV-patient presenting 10 years after hospitalization for cryptococcal meningitis.

Keywords: Cryptococcal Meningitis; Geographic atrophy

Abbreviations: CMV: Cytomegalovirus; CF: Counting Fingers; OCT: Optical Coherence Tomography; RPE: Retinal Pigment Epithelium